Moreover, our study did not analyse the relationship between 18F-FES uptake and ESR1 gene amplification and mutation in the tumour biopsy, as these assays provide insufficient data at present to guide therapy for HR + /HER2- MBC[41] and are not performed routinely in our centre. Here, ERBB2 is linked to neoplasm.